Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Sildenafil 10mg oral tablet (participants <20kg), or 20mg oral tablet (participants ≥20kg)
Pravastatin 20 mg oral tablet (ages <13 years), or 40 mg oral tablet (≥14 years)
Locations
1
United States
Children's Mercy Hospital
Kansas City, Missouri, United States
Start Date
March 1, 2024
Primary Completion Date
December 31, 2026
Completion Date
December 31, 2026
Last Updated
January 2, 2026
NCT06258382
NCT07220226
NCT06197763
NCT00964782
Lead Sponsor
Children's Mercy Hospital Kansas City
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions